The Bridge

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Shedding Light on SUN ORB's Indoor Revolution Sometimes, the best ideas come from simple needs, like wanting a bit of sunshine in your life. That's the deal with this SUN ORB concept—an invention dreamed up by a chap from Oklahoma who's spent too much time away from the natural light outside. We're talking about a wellness-oriented lighting idea that has big ambitions...

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...

Legal Eagles Soar in the Sunshine State Right out of the gate, it looks like Greenberg Traurig's West Palm Beach office is getting all the spotlight. Twenty-one of their legal hotshots have clinched spots on Palm Beach Illustrated's 2026 'Top Lawyers' list. For those keeping score, that's a hefty nod in this competitive market. A Closer Look at the Selection Process Now,...

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

BioCardia Unveils Promising Results in CardiAMP Cell Therapy BioCardia, Inc. (NASDAQ: BCDA), a pioneer in cell therapy for cardiovascular conditions, recently shared the groundbreaking results from its CardiAMP trial. This innovative cellular therapy targets chronic myocardial ischemia, a serious health issue impacting many individuals due to reduced blood flow to the...

Growth of the Pharmacovigilance Software Market The global pharmacovigilance and drug safety software market is set to experience remarkable growth, projecting an increase of USD 69.1 million over the forecast period running from 2024 to 2028. A key factor influencing this expansion is the rising rates of adverse drug events, which have prompted healthcare and...

Quaker Houghton Reports Strong Financial Performance for Q3 Quaker Houghton, recognized as a leading provider of industrial process fluids, demonstrated solid performance in its third quarter results. The company's net sales reached an impressive $493.8 million, marking a notable increase of 7% compared to the prior year. This growth was driven by an organic sales volume...

Nerivio® REN wearable made waves when it gained wider Medicaid coverage back in 2024, opening up significant avenues for migraine treatment across several states like Arizona, New Jersey, Ohio, and Virginia. The buzz was palpable on the trading floor as this initiative could potentially bring affordable migraine relief to seven million more people. You know how these...

Enhancing Leadership at Augustine Therapeutics Augustine Therapeutics recently announced a significant enhancement to its management team, with the appointments of Virginie Cartage as Chief Financial Officer (CFO) and Dr. Andy Hu as Chief Business Officer (CBO). These strategic additions come at a pivotal moment as the company advances its lead program, AGT-100216, into...